HROW
HROW
NASDAQ · Pharmaceuticals

Harrow Inc

$43.87
+1.09 (+2.55%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -43.8% upside
Low Target $15.17
Average Target $24.64
High Target $37.47
Current Price $43.87
Current
$43.87
Target
$24.64
$15.17 $24.64 avg $37.47
Scenario Analysis
Bear Case
$15.17
-65.4%
Low target
Base Case
$24.64
-43.8%
Avg target
Bull Case
$37.47
+-14.6%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$54.85
-20.0% from high
52-Week Low
$28.54
+53.7% from low
Target vs 52W High
$24.64
-55.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%